|Year : 2012 | Volume
| Issue : 3 | Page : 104-106
Splenosis after splenectomy and spleen tissue autoimplantation: Late followup study
Carlos T Brandt1, S. C. S. Brandão2, A. L. C. Domingues3, LA Gondra4, RA Viana4
1 Department of Pediatric Surgery, Federal University of Pernambuco (UFPE), Brazil
2 Department of Nuclear Medicine, Federal University of Pernambuco (UFPE), Brazil
3 Department of Gastroenterology, Federal University of Pernambuco (UFPE), Brazil
4 Medical Student, Federal University of Pernambuco (UFPE) and Scholarship of Scientific Initiation - Brazilian National Council for Research (CNPq), Brazil
|Date of Web Publication||6-Jul-2012|
Carlos T Brandt
Av. Moraes Rego S/N, 50670-420, Recife, PE
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aim : In children suffering from severe hepatosplenic schistosomiasis, the surgical protocol includes splenectomy and autoimplantation of spleen morsels in the major omentum, which has the potential of reducing the overwhelming postsplenectomy infection (OPSI). The purpose of the study was to evaluate the remaining splenosis, with the mean postoperative followup of 12.1 ± 5.6 years; to compare the efficacy of the 2 evaluation tools. Materials and Methods : Nineteen patients underwent, when they were children, portal decompression and autoimplantation of spleen. After a mean age of 23.4 ± 5.3 years, they were investigated regarding the number of infections and OPSI. They had undergone hepatosplenic scintigraphy with labeled colloidal SnTc 99m and abdominal ultrasound. It was considered efficient splenosis when the patients presented with 5 or more spleen nodules. The evaluation was performed by 3 observers. Results : None of the patients had increased infection rate or developed OPSI. Sixteen (84.2%) presented efficient splenosis. Conclusions : The remaining postoperative splenosis was considered efficient in the majority of patients in the long-term followup; and nuclear medicine was considered the gold standard for splenosis evaluation.
Keywords: Hepatosplenic schistosomiasis mansoni, over-whelming postsplenectomy infection, splenectomy, splenosis
|How to cite this article:|
Brandt CT, Brandão S, Domingues A, Gondra L A, Viana R A. Splenosis after splenectomy and spleen tissue autoimplantation: Late followup study. J Indian Assoc Pediatr Surg 2012;17:104-6
|How to cite this URL:|
Brandt CT, Brandão S, Domingues A, Gondra L A, Viana R A. Splenosis after splenectomy and spleen tissue autoimplantation: Late followup study. J Indian Assoc Pediatr Surg [serial online] 2012 [cited 2020 Nov 24];17:104-6. Available from: https://www.jiaps.com/text.asp?2012/17/3/104/98120
| Introduction|| |
The hepatosplenic schistosomiasis mansoni (HSM) is hyperendemic in Brazil and is treated with praziquantel. , The main factor of morbidity is the portal hypertension. In severe cases, surgery is the treatment for portal decompression by splenectomy and ligature of the left gastric vein, which reduces portal hypertension. Autoimplantation of spleen tissue in the omentum has the potential to reduce the risk of overwhelming postsplenectomy infection (OPSI). ,,,,,,,,
The purpose of this study was to evaluate the presence and functionality of autoimplanted spleen tissue in the major omentum (splenosis) in children with HSM who underwent splenectomy and ligature of the left gastric vein, with a mean followup of 12.1 ± 5.6 years after surgery, and also to compare the effectiveness between the used methods (ultrasound and nuclear medicine).
| Materials and Methods|| |
The study was observational, prospective, and was approved by the Ethics Committee of the hospital. The patients consisted of 94 children with HSM who underwent surgery when they were between 7 and 18 years of age. The surgical procedure was splenectomy, ligature of left gastric vein, and autoimplantation of spleen tissue into a pouch of the omentum, between the years 1990 and 2005. The representative and randomized sample size was calculated in 20 patients. After randomization, one randomly selected patient died, and so the final sample was 19 patients with mean age of 23.4 ± 5.3 years.
In the original surgical procedure, about 8-12 fragments of spleen tissue without capsule, weighing approximately 100 g were implanted, in the major omentum (omental pouch). These patients were evaluated for infections or sepsis development. In addition, these patients underwent abdominal ultrasound  and hepatosplenic scintigraphy with labeled colloidal stannous chloride (SnTc99m) single photon emission computer tomography/computer tomography SPECT/CT. This examination was done in 20 min after tracer injection, SnTc 99m colloid. This material was injected, and once captured by the phagocytic system, which is part of the innate immune system, of the liver and spleen. After administration of the radiotracer the patient was taken to the gamma camera, for evaluation and pictures were taken in the anterior, posterior, right, left, and oblique positions.
The 2 methods aimed at detecting the presence of splenic nodules, and also scintigraphy function to evaluate the splenosis by counting the nodules visualized on image examination. Splenosis was considered satisfactory when the number of nodules was 5 or more, using 3 observers' evaluation.
| Results|| |
There was no increase in the infection rate and no OPSI in all patients of this series. The splenosis evaluation by ultrasound had less sensibility than hepatosplenic scintigraphy with labeled colloidal stannous chloride SnTc 99m SPECT/CT. In 10 patients (52.6%) splenosis in ultrasound were well defined [Figure 1]; however, in 9 patients, splenic nodules were not found.
All patients showed spleen morsels in SPECT/CT images [Figure 2] and most of the time their location were in the left flank and left iliac abdominal region. Sixteen (84.2%) patients presented effective splenosis with 5 or more morsels. But, in 3 (15.8%) the definition of 5 morsels was not precise. The mean number of morsels seen in the nuclear medicine was 6.8 ± 1.8. The splenosis SnTc 99m uptake was compared with SnTc 99m liver uptake in the same projection and classified in 4 grades: grade I-mild uptake, grade II-mild to moderate uptake, grade III-moderate uptake and grade IV high uptake of spleen morsels. Mild to moderate radiotracer uptake (grade II) was found in 63.15% of the patients.
|Figure 2: Planar images of hepatosplenic scintigraphy with SnTc99m in anterior and left anterior oblique views|
Click here to view
| Discussion|| |
The surgery to decompress the portal system in patients with HSM has been carried out in various ways, including bypass and porto-systemic-azygos disconnection. ,,
The maintenance of spleen tissue, after splenectomy is very important for the patient's immunity, particularly in children. , Even in situations where the disease affects major portion of the spleen, as in the case of large hemangioma, partial splenectomy may be the best alternative. ,
Some studies , of splenic nodules self-implantation into the major omentum has been done using sulfur colloid labeled (splenosis) with technetium-99; however, in this series of late followup tin was used. This mineral has good specificity for marking the reticuloendothelial system, where quality control is done properly.  In this sense, nuclear medicine was of greater accuracy and specificity for mapping of the remaining splenic nodules after an average followup of more than 10 years.
The study by ultrasound has limitations, because it is a test observer and machine dependent. In the current study, the examination was performed by one of the authors, who was not a radiologist, using a machine for research purposes. It is considered that if the image investigation had been done by an experienced radiologist and better ultrasound  the results could be different when comparing the two methods.
The most important clinical fact is the clinical observation that in no patient infection rate increased and they did not develop fulminant sepsis (OPSI) after splenectomy. Previous studies from the same group showed that tutfsin production is maintained in these patients;  as well as the levels of IgM and IgG are also maintained in normal levels.  Furthermore, the positive response to pneumococcal vaccination is achieved by 65% of the patients.  This information tends to support the hypothesis of efficient splenosis in the long-term followup seems to be associated with immune protection for OPSI in these patients after splenectomy, even on those who have other diseases rather than hepatosplenic schistosomiasis mansoni.
| References|| |
|1.||Coutinho AD, Silva ML, Gonçalves JF. Estudo epidemiológico da esquistossomose mansônica em áreas de irrigação do Nordeste brasileiro. Cad Saúde Pública 1992;8:302-10. |
|2.||Abdul-Ghani R, Loutfy N, El-Sahn A, Hassan A. Current chemotherapy arsenal for schistosomiasis mansoni: Alternatives and challenges. Parasitol Res 2009;104:955-65. |
|3.||Brandt CT, Maciel DT, Frei Caneca AO. Esplenose associada ao tratamento cirúrgico da hipertensão porta esquistossomótica na criança: Avaliação de dez anos. An Fac Med Univ Fed Pernamb 1999;44:15-20. |
|4.||Brandt CT, Araujo LB, Barbosa CM. Auto transplantation of spleen tissue in children with mansonic schistosomiasis who underwent splenectomy: Evaluation of splenic residual functions. Acta Cir Bras 1998;13:212-6. |
|5.||Brandt CT, Tavares MD, Caneca OA. Splenectomy associated with ligature of the left gastric vein in children with schistosomiasis: Analysis of the hepatic functional reserve. Acta Cir Bras 1997;12:150-3. |
|6.||Brandt CT, Tavares MD, Frei CO, Barbosa CC, Bragante LA. Auto transplant of spleen tissue in children with schistosomiasis: Evaluation of splenic function after splenosis. Mem Inst Oswaldo Cruz 2001;96:117-22. |
|7.||Resende V, Petroianu A. Late functional study of human spleen autotrasplantation after severe splenic injuries. Rev Col Bras Cir 2001;28:167-72. |
|8.||Resende V, Petroianu A. Funções do remanescente esplênico após esplenectomia subtotal para o tratamento de lesões complexas do baço humano. Rev Assoc Med Bras 2002;48:26-31. |
|9.||Marques RG, Petroianu Y, Coelho JM. Bacterial phagocytosis by macrophage of autogenous splenic implant. Braz J Biol 2003;63:491-5. |
|10.||Brandt CT, Barbosa de Castro CM, Lavor SM, Castro FM. Fagocitose e viabilidade monocitária de pacientes com esquistossomose mansônica na forma hepatoesplênica submetidos à esplenectomia e ao auto-implante esplênico. Rev Soc Bras Med Trop 2006;39:439-45. |
|11.||Brandt CT, Leite CR, Castro CM, Manhães-de-Castro R, Brandt FC. Esquitossomose mansônica hepatoesplênica humana: Produção de TNF-alfa em monócitos. Rev Col Bras Cir 2003;30:447-51. |
|12.||Vasconcelos CH, Cardoso PC, Quirino WC, Massara CL, Amaral GL, Cordeiro R. Evaluation of schistosomiasis mansoni control measures in Sabará, Minas Gerais State, Brazil, 1980-2007. Cad Saúde Pública 2009;25:997-1006. |
|13.||De Cleva R, Herman P, D'albuquerque LA, Pugliese V, Santarem OL, Saad WA. Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: A comparative study in schistomomal portal hypertension. World J Gastroenterol 2007;13:5471-5. |
|14.||Carvalho DL, Capua A Jr, Leme PL. Portal flow and hepatic function after splenectomy and esophagogastric devascularization. Int Surg 2008;93:314-20. |
|15.||Petroianu A, De Oliveira AE, Alberti LR. Hypersplenism in schistosomatic portal hypertension. Arch Med Res 2005;36:496-501. |
|16.||Petroianu A, Brandt CT, Alencar LF. Esplenectomia parcial para tratar hemangioma esplênico. Rev Col Bras Cir 2008;35:132-5. |
|17.||Marques FL, Okamoto MR, Buchpiguel CA. Alguns aspectos sobre geradores e radiofármacos de tecnécio-99m e seus controles de qualidade. Radiol Bras 2001;34:233-9. |
|18.||Brandt CT, Bragante AL, Barbosa CM. Auto transplantation of spleen tissue in children with mansonic schistosomiasis who underwent splenectomy: Evaluation of splenic residual functions. Acta Cir Bras 1994;13:212-6. |
[Figure 1], [Figure 2]